Abstract
Background: Stem cell transplantation has been widely performed to treat many different diseases in adults. However, its indication is still limited in children. Since 2014, we have been doing stem cell transplantation for various incurable diseases in children. The aim of our report is to evaluate safety and efficacy of stem cell transplantation for incurable diseases in children.
 Results
 From 2014-2017, stem cell transplantation has been performed for different conditions including :
 
 Cerebral palsy due to oxygen deprivation, cerebral palsy related to neonatal icterus , Cerebral palsy after meningitis/encephalitis , cerebral palsy after brain trauma ,
 Brain damage due to drowning
 Autism
 Liver cirrhosis due to biliary atresia
 Bowel and urinary dysfunction after meningocele repair
 Brongchopulmonary dysplasia
 Intestinal neural dysplasia
 
 There were no death related to stem cell transplantation. No severe side effects occurred. Early outcomes are promising.
 Conclusion : Stem cell transplantation is safe and effectiveness in treatment of different incurable diseases in children
Highlights
Stem cell transplantation has been widely performed to treat many different diseases in adults
Intestinal neural dysplasia There were no death related to stem cell transplantation
Stem cell transplantation is safe and effectiveness in treatment of different incurable diseases in children
Summary
Stem cell transplantation has been widely performed to treat many different diseases in adults.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.